Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients

Molecular Microbiology

Volumn 64, Issue 2, 2007, Pages 512-533

  D'Argenio, David A ^a   Wu, Manhong ^a   Hoffman, Lucas R ^b   Kulasekara, Hemantha D ^a   Déziel, Eric ^c   Smith, Eric E ^a   Nguyen, Hai ^a   Ernst, Robert K ^a   Larson Freeman, Theodore J ^a   Spencer, David H ^a   Brittnacher, Mitchell ^a   Hayden, Hillary S ^a   Selgrade, Sara ^a   Klausen, Mikkel ^d   Goodlett, David R ^a   Burns, Jane L ^b   Ramsey, Bonnie W ^b   Miller, Samuel I ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; BETA LACTAMASE; CARBON; CEFTAZIDIME; NITROGEN; PROTEIN CBRB; PROTEIN LASR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AIRWAY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM MUTANT; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; ENZYME ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GRAM NEGATIVE INFECTION; HUMAN; INFANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADAPTATION, BIOLOGICAL; ALLELES; AMIDES; AMINO ACID SEQUENCE; AMINO ACIDS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DNA-BINDING PROTEINS; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUINOLINES; RESPIRATORY SYSTEM; SUCCINIC ACID; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 34247333058     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2007.05678.x     Document Type: Article

References (110)

1. Allesen-Holm, M., Barken, K.B., Yang, L., Klausen, M., Webb, J.S., Kjelleberg, S., et al. (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59: 1114 1128.
2. Barth, A.L. Pitt, T.L. (1995a) Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 33: 37 40.
3. Barth, A.L. Pitt, T.L. (1995b) Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol 33: 2192 2194.
4. Barth, A.L. Pitt, T.L. (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110 119.
5. Beatson, S.A., Whitchurch, C.B., Semmler, A.B. Mattick, J.S. (2002) Quorum sensing is not required for twitching motility in Pseudomonas aeruginosa. J Bacteriol 184: 3598 3604.
6. Blumer, C. Haas, D. (2000) Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis. Arch Microbiol 173: 170 177.
7. Bochner, B.R. (2003) New technologies to assess genotype-phenotype relationships. Nat Rev Genet 4: 309 314.
8. Brammar, W.J., Charles, I.G., Matfield, M., Liu, C.P., Drew, R.E. Clarke, P.H. (1987) The nucleotide sequence of the amiE gene of Pseudomonas aeruginosa. FEBS Lett 215: 291 294.
9. Burns, J.L., Gibson, R.L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., et al. (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183: 444 452.
10. Cabrol, S., Olliver, A., Pier, G.B., Andremont, A. Ruimy, R. (2003) Transcription of quorum-sensing system genes in clinical and environmental isolates of Pseudomonas aeruginosa. J Bacteriol 185: 7222 7230.
11. Calfee, M.W., Coleman, J.P. Pesci, E.C. (2001) Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 98: 11633 11637.
12. Choi, K.H. Schweizer, H.P. (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5: 30.
13. Chugani, S.A., Whiteley, M., Lee, K.M., D'Argenio, D., Manoil, C. Greenberg, E.P. (2001) QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 98: 2752 2757.
14. Cooper, M., Tavankar, G.R. Williams, H.D. (2003) Regulation of expression of the cyanide-insensitive terminal oxidase in Pseudomonas aeruginosa. Microbiology 149: 1275 1284.
15. Cosson, P., Zulianello, L., Join-Lambert, O., Faurisson, F., Gebbie, L., Benghezal, M., et al. (2002) Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol 184: 3027 3033.
16. D'Argenio, D.A. (2004) The pathogenic lifestyle of Pseudomonas aeruginosa in model systems of virulence. In Pseudomonas, vol. I. Ramos, J.L. (ed.). New York, NY: Kluwer, pp. 477 503.
17. D'Argenio, D.A., Calfee, M.W., Rainey, P.B. Pesci, E.C. (2002) Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J Bacteriol 184: 6481 6489.
18. De Vos, D., De Chial, M., Cochez, C., Jansen, S., Tümmler, B., Meyer, J.M. Cornelis, P. (2001) Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175: 384 388.
19. Dénervaud, V., TuQuoc, P., Blanc, D., Favre-Bonté, S., Krishnapillai, V., Reimmann, C., et al. (2004) Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients. J Clin Microbiol 42: 554 562.
20. Déziel, E., Lépine, F., Milot, S., He, J., Mindrinos, M.N., Tompkins, R.G. Rahme, L.G. (2004) Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2- heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci USA 101: 1339 1344.
21. Doggett, R.G., Harrison, G.M. Wallis, E.S. (1964) Comparison of some properties of Pseudomonas aeruginosa isolated from infections in persons with and without cystic fibrosis. J Bacteriol 87: 427 431.
22. Ernst, R.K., D'Argenio, D.A., Ichikawa, J.K., Bangera, M.G., Selgrade, S., Burns, J.L., et al. (2003) Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol 5: 1341 1349.
23. Ernst, R.K., Adams, K.N., Moskowitz, S.M., Kraig, G.M., Kawasaki, K., Stead, C.M., et al. (2006) The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J Bacteriol 188: 191 201.
24. Farrell, M.J. Finkel, S.E. (2003) The growth advantage in stationary-phase phenotype conferred by rpoS mutations is dependent on the pH and nutrient environment. J Bacteriol 185: 7044 7052.
25. Fiske, M.J., Whitaker, R.J. Jensen, R.A. (1983) Hidden overflow pathway to L-phenylalanine in Pseudomonas aeruginosa. J Bacteriol 154: 623 631.
26. Friedheim, E.A.H. (1931) Pyocyanine, an accessory respiratory enzyme. J Exp Med 54: 207 221.
27. Fuqua, C. (2006) The QscR quorum-sensing regulon of Pseudomonas aeruginosa: an orphan claims its identity. J Bacteriol 188: 3169 3171.
28. Furste, J.P., Pansegrau, W., Frank, R., Blocker, H., Scholz, P., Bagdasarian, M. Lanka, E. (1986) Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48: 119 131.
29. Gallagher, L.A., McKnight, S.L., Kuznetsova, M.S., Pesci, E.C. Manoil, C. (2002) Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa. J Bacteriol 184: 6472 6480.
30. Gambello, M.J. Iglewski, B.H. (1991) Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173: 3000 3009.
31. Gibson, R.L., Burns, J.L. Ramsey, B.W. (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168: 918 951.
32. Giwercman, B., Lambert, P.A., Rosdahl, V.T., Shand, G.H. Høiby, N. (1990) Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J Antimicrob Chemother 26: 247 259.
33. Govan, J.R. Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539 574.
34. Guina, T., Wu, M., Miller, S.I., Purvine, S.O., Yi, E.C., Eng, J., et al. (2003) Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation. J Am Soc Mass Spectrom 14: 742 751.
35. Haas, D. (2006) Cost of cell-cell signalling in Pseudomonas aeruginosa: why it can pay to be signal-blind. Nat Rev Microbiol 4: 562.
36. Hadley, P. (1924) Transmissible lysis of Bacillus pyocyaneus. J Infect Dis 34: 260 304.
37. Han, D.K., Eng, J., Zhou, H. Aebersold, R. (2001) Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol 19: 946 951.
38. Hanahan, D. Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100: 57 70.
39. Hancock, R.E., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P. Pier, G.B. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170 177.
40. Häse, C.C., Fedorova, N.D., Galperin, M.Y. Dibrov, P.A. (2001) Sodium ion cycle in bacterial pathogens: evidence from cross-genome comparisons. Microbiol Mol Biol Rev 65: 353 370.
41. Häussler, S., Tümmler, B., Weissbrodt, H., Rohde, M. Steinmetz, I. (1999) Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 29: 621 625.
42. Hayes, M.V. Orr, D.C. (1983) Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 12: 119 126.
43. Hentzer, M., Wu, H., Andersen, J.B., Riedel, K., Rasmussen, T.B., Bagge, N., et al. (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22: 3803 3815.
44. Heurlier, K., Dénervaud, V., Haenni, M., Guy, L., Krishnapillai, V. Haas, D. (2005) Quorum-sensing-negative (lasR) mutants of Pseudomonas aeruginosa avoid cell lysis and death. J Bacteriol 187: 4875 4883.
45. Heurlier, K., Dénervaud, V. Haas, D. (2006) Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J Med Microbiol 296: 93 102.
46. Hoffmann, N., Rasmussen, T.B., Jensen, P.O., Stub, C., Hentzer, M., Molin, S., et al. (2005) Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 73: 2504 2514.
47. Hogardt, M., Hoboth, C., Schmoldt, S., Henke, C., Bader, L. Heesemann, J. (2007) Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 195: 70 80.
48. Høiby, N. (1975) Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases. Acta Pathol Microbiol Scand Suppl 83: 549 552.
49. Horsburgh, M.J., Wiltshire, M.D., Crossley, H., Ingham, E. Foster, S.J. (2004) PheP, a putative amino acid permease of Staphylococcus aureus, contributes to survival in vivo and during starvation. Infect Immun 72: 3073 3076.
50. Hummerjohann, J., Kuttel, E., Quadroni, M., Ragaller, J., Leisinger, T. Kertesz, M.A. (1998) Regulation of the sulfate starvation response in Pseudomonas aeruginosa: role of cysteine biosynthetic intermediates. Microbiology 144: 1375 1386.
51. Jain, M., Ramirez, D., Seshadri, R., Cullina, J.F., Powers, C.A., Schulert, G.S., et al. (2004) Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 42: 5229 5237.
52. Janda, J.M., Sheehan, D.J. Bottone, E.J. (1982) Recovery of Pseudomonas aeruginosa colonial dissociants on a protease detection medium. J Clin Microbiol 15: 178 180.
53. Kawasaki, S., Arai, H., Kodama, T. Igarashi, Y. (1997) Gene cluster for dissimilatory nitrite reductase (nir) from Pseudomonas aeruginosa: sequencing and identification of a locus for heme d1 biosynthesis. J Bacteriol 179: 235 242.
54. Knight, C.G., Zitzmann, N., Prabhakar, S., Antrobus, R., Dwek, R., Hebestreit, H. Rainey, P.B. (2006) Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network. Nat Genet 38: 1015 1022.
55. Köhler, T., van Delden, C., Curty, L.K., Hamzehpour, M.M. Pechere, J.C. (2001) Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 183: 5213 5222.
56. Kong, K.F., Jayawardena, S.R., Del Puerto, A., Wiehlmann, L., Laabs, U., Tümmler, B. Mathee, K. (2005a) Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase. Gene 358: 82 92.
57. Kong, K.F., Jayawardena, S.R., Indulkar, S.D., Del Puerto, A., Koh, C.L., Høiby, N. Mathee, K. (2005b) Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob Agents Chemother 49: 4567 4575.
58. Kresse, A.U., Blocker, H. Römling, U. (2006) ISPa20 advances the individual evolution of Pseudomonas aeruginosa clone C subclone C13 strains isolated from cystic fibrosis patients by insertional mutagenesis and genomic rearrangements. Arch Microbiol 185: 245 254.
59. Leatham, M.P., Stevenson, S.J., Gauger, E.J., Krogfelt, K.A., Lins, J.J., Haddock, T.L., et al. (2005) Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources. Infect Immun 73: 8039 8049.
60. Lee, B., Haagensen, J.A., Ciofu, O., Andersen, J.B., Høiby, N. Molin, S. (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 5247 5255.
61. Lépine, F., Déziel, E., Milot, S. Rahme, L.G. (2003) A stable isotope dilution assay for the quantification of the Pseudomonas quinolone signal in Pseudomonas aeruginosa cultures. Biochim Biophys Acta 1622: 36 41.
62. Lépine, F., Milot, S., Déziel, E., He, J. Rahme, L.G. (2004) Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa. J Am Soc Mass Spectrom 15: 862 869.
63. Lequette, Y., Lee, J.H., Ledgham, F., Lazdunski, A. Greenberg, E.P. (2006) A distinct QscR regulon in the Pseudomonas aeruginosa quorum-sensing circuit. J Bacteriol 188: 3365 3370.
64. Luján, A.M., Moyano, A.J., Segura, I., Argaraña, C.E. Smania, A.M. (2007) Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. Microbiology 153: 225 237.
65. Maciá, M.D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J.L. Oliver, A. (2005) Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49: 3382 3386.
66. Mahenthiralingam, E., Campbell, M.E. Speert, D.P. (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596 605.
67. Maseda, H., Saito, K., Nakajima, A. Nakae, T. (2000) Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 192: 107 112.
68. Muh, U., Schuster, M., Heim, R., Singh, A., Olson, E.R. Greenberg, E.P. (2006) Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob Agents Chemother 50: 3674 3679.
69. Nesvizhskii, A.I., Keller, A., Kolker, E. Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646 4658.
70. Nguyen, D. Singh, P.K. (2006) Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci USA 103: 8305 8306.
71. Nishijyo, T., Haas, D. Itoh, Y. (2001) The CbrA-CbrB two-component regulatory system controls the utilization of multiple carbon and nitrogen sources in Pseudomonas aeruginosa. Mol Microbiol 40: 917 931.
72. O'Callaghan, C.H., Morris, A., Kirby, S.M. Shingler, A.H. (1972) Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1: 283 288.
73. Ohman, D.E. Chakrabarty, A.M. (1982) Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun 37: 662 669.
74. Oliver, A., Cantón, R., Campo, P., Baquero, F. Blázquez, J. (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251 1254.
75. Palmer, K.L., Mashburn, L.M., Singh, P.K. Whiteley, M. (2005) Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187: 5267 5277.
76. Pesci, E.C., Milbank, J.B., Pearson, J.P., McKnight, S., Kende, A.S., Greenberg, E.P. Iglewski, B.H. (1999) Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 96: 11229 11234.
77. Pirnay, J.P., Matthijs, S., Colak, H., Chablain, P., Bilocq, F., Van Eldere, J., et al. (2005) Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ Microbiol 7: 969 980.
78. Price-Whelan, A., Dietrich, L.E. Newman, D.K. (2006) Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol 2: 71 78.
79. Ramsey, B.W., Pepe, M.S., Quan, J.M., Otto, K.L., Montgomery, A.B., Williams-Warren, J., et al. (1999) Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340: 23 30.
80. Römling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H. Tümmler, B. (1994) Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 170: 1616 1621.
81. Rosenfeld, M., Gibson, R.L., McNamara, S., Emerson, J., Burns, J.L., Castile, R., et al. (2001) Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32: 356 366.
82. Salunkhe, P., Smart, C.H., Morgan, J.A., Panagea, S., Walshaw, M.J., Hart, C.A., et al. (2005) A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187: 4908 4920.
83. Schaber, J.A., Carty, N.L., McDonald, N.A., Graham, E.D., Cheluvappa, R., Griswold, J.A. Hamood, A.N. (2004) Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 53: 841 853.
84. Schuster, M. Greenberg, E.P. (2006) A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol 296: 73 81.
85. Schuster, M., Lostroh, C.P., Ogi, T. Greenberg, E.P. (2003) Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185: 2066 2079.
86. Sheehan, D.J., Janda, J.M. Bottone, E.J. (1982) Pseudomonas aeruginosa: changes in antibiotic susceptibility, enzymatic activity, and antigenicity among colonial morphotypes. J Clin Microbiol 15: 926 930.
87. Shrout, J.D., Chopp, D.L., Just, C.L., Hentzer, M., Givskov, M. Parsek, M.R. (2006) The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional. Mol Microbiol 62: 1264 1277.
88. Silo-Suh, L., Suh, S.J., Phibbs, P.V. Ohman, D.E. (2005) Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase. J Bacteriol 187: 7561 7568.
89. Smith, E.E., Buckley, D.G., Wu, Z., Saenphimmachak, C., Hoffman, L.R., D'Argenio, D.A., et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103: 8487 8492.
90. Smith, R.S. Iglewski, B.H. (2003) Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest 112: 1460 1465.
91. Sokol, P.A., Ohman, D.E. Iglewski, B.H. (1979) A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa. J Clin Microbiol 9: 538 540.
92. Spencer, D.H., Kas, A., Smith, E.E., Raymond, C.K., Sims, E.H., Hastings, M., et al. (2003) Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 185: 1316 1325.
93. Stanier, R.Y., Palleroni, N.J. Doudoroff, M. (1966) The aerobic pseudomonads: a taxonomic study. J Gen Microbiol 43: 159 271.
94. Vannini, A., Volpari, C., Gargioli, C., Muraglia, E., Cortese, R., De Francesco, R., et al. (2002) The crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA. Embo J 21: 4393 4401.
95. Wagner, V.E., Bushnell, D., Passador, L., Brooks, A.I. Iglewski, B.H. (2003) Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 185: 2080 2095.
96. Wahba, A.H. (1964) Metallic sheen in Pseudomonas aeruginosa. Nature 204: 502.
97. Wensinck, F., van Dalen, A. Wedema, M. (1967) Iridescent material and the effect of iron on its production by Pseudomonas aeruginosa. Antonie Van Leeuwenhoek 33: 73 86.
98. Whitchurch, C.B., Beatson, S.A., Comolli, J.C., Jakobsen, T., Sargent, J.L., Bertrand, J.J., et al. (2005) Pseudomonas aeruginosa fimL regulates multiple virulence functions by intersecting with Vfr-modulated pathways. Mol Microbiol 55: 1357 1378.
99. Wolff, J.A., MacGregor, C.H., Eisenberg, R.C. Phibbs, P.V. Jr (1991) Isolation and characterization of catabolite repression control mutants of Pseudomonas aeruginosa PAO. J Bacteriol 173: 4700 4706.
100. Wolfgang, M.C., Lee, V.T., Gilmore, M.E. Lory, S. (2003) Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell 4: 253 263.
101. Wolter, D.J., Hanson, N.D. Lister, P.D. (2004) Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett 236: 137 143.
102. Wu, M., Guina, T., Brittnacher, M., Nguyen, H., Eng, J. Miller, S.I. (2005) The Pseudomonas aeruginosa proteome during anaerobic growth. J Bacteriol 187: 8185 8190.
103. Xiao, G., Déziel, E., He, J., Lépine, F., Lesic, B., Castonguay, M.H., et al. (2006) MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR-class regulatory protein, has dual ligands. Mol Microbiol 62: 1689 1699.
104. Zambrano, M.M., Siegele, D.A., Almiron, M., Tormo, A. Kolter, R. (1993) Microbial competition: Escherichia coli mutants that take over stationary phase cultures. Science 259: 1757 1760.
105. Zhang, R.G., Pappas, T., Brace, J.L., Miller, P.C., Oulmassov, T., Molyneaux, J.M., et al. (2002) Structure of a bacterial quorum-sensing transcription factor complexed with pheromone and DNA. Nature 417: 971 974.
106. Zhu, H., Bandara, R., Conibear, T.C., Thuruthyil, S.J., Rice, S.A., Kjelleberg, S., et al. (2004) Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci 45: 1897 1903.
107. Zierdt, C.H. (1971) Autolytic nature of iridescent lysis in Pseudomonas aeruginosa. Antonie Van Leeuwenhoek 37: 319 337.
108. Zierdt, C.H. Schmidt, P.J. (1964) Dissociation in Pseudomonas aeruginosa. J Bacteriol 87: 1003 1010.
109. Zinser, E.R. Kolter, R. (1999) Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase. J Bacteriol 181: 5800 5807.
110. Zinser, E.R. Kolter, R. (2004) Escherichia coli evolution during stationary phase. Res Microbiol 155: 328 336.